Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Relaxin-like factor and relaxin analogues described

Feb. 21, 1997

Akzo reports peptides for specific tolerance therapy

Feb. 20, 1997

SKB prepares cytokine inhibitors

Feb. 19, 1997

University of California researchers report pseudopterosin derivatives

Feb. 19, 1997

Inhibitors of cell adhesion disclosed by Tanabe

Feb. 18, 1997

MGI Pharma seeks FDA approval of new indication for Salagen Tablets

Feb. 12, 1997

Arthritis gene therapy appears to hold promise

Feb. 12, 1997

Selective gelatinase inhibitor described by British Biotech

Feb. 11, 1997

Meiji Milk discloses new gold complex

Feb. 10, 1997

New use of ciclosporin recommended for approval

Feb. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...